How often it is a primary outcome
Picture Naming Test43% of 466 studies
Vocabulary Test37% of 199 studies
Token Commands Task33% of 36 studies
Lexical Decision Task32% of 22 studies
Serial Naming Task32% of 22 studies
Clinical trials data
Every registered study on ClinicalTrials.gov that names the Lexical Decision Task in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.
Stroke3 studies, 0 as a primary outcome
Depression and bipolar disorder2 studies, 0 as a primary outcome
Dementia and Alzheimer's1 study, 0 as a primary outcome
Mild cognitive impairment1 study, 0 as a primary outcome
Parkinson's disease1 study, 0 as a primary outcome
ADHD1 study, 0 as a primary outcome
Cancer1 study, 0 as a primary outcome
Aging, frailty and exercise1 study, 1 as a primary outcome
Substance use and addiction1 study, 0 as a primary outcome
Sleep and sleep disorders1 study, 0 as a primary outcome
Anxiety, PTSD and OCD1 study, 1 as a primary outcome
Cardiovascular disease1 study, 0 as a primary outcome
Lung disease1 study, 0 as a primary outcome
Other conditions8 studies, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Picture Naming Test43% of 466 studies
Vocabulary Test37% of 199 studies
Token Commands Task33% of 36 studies
Lexical Decision Task32% of 22 studies
Serial Naming Task32% of 22 studies
A test as a primary outcomeOnly in secondary or other outcomes
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 2 | 0 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 3 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 3 | 1 |
| 2025 | 2 | 1 |
| 2026 | 2 | 1 |
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 16 | 41 | 22 to 77 |
A test as a primary outcomeOnly in secondary or other outcomes
18 of the 22 outcome measures give a duration. A single visit counts as within a day.
Intervention types as registered. A study can list several; observational studies often list none.
10 countries in all. A study with sites in several counts in each; 1 list no site.
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed studies that name the Lexical Decision Task: 4 of 15, 27%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed studies that name the Lexical Decision Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 7% | 776, 10% |
| Results on ClinicalTrials.gov only | 1, 7% | 1,139, 14% |
| A results paper only | 2, 13% | 1,711, 22% |
| Neither | 11, 73% | 4,327, 54% |
Serial Naming Task3 studies, 1 as a primary outcome
Stroop Color-Word Test3 studies, 1 as a primary outcome
Emoji Emotion Recognition2 studies, 2 as a primary outcome
Choice Reaction Time2 studies, 1 as a primary outcome
Delay Discounting2 studies, 1 as a primary outcome
Go/No-Go Task2 studies, 1 as a primary outcome
Card Sorting Test (Berg)2 studies, 0 as a primary outcome
N-Back Task2 studies, 0 as a primary outcome
Brief Implicit Association Test1 study, 1 as a primary outcome
Implicit Association Test (IAT)1 study, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.
| Start year | Lexical Decision Task | Serial Naming Task | Stroop Color-Word Test | Emoji Emotion Recognition |
|---|---|---|---|---|
| 2000 | 0 | 0 | 3 | 0 |
| 2001 | 0 | 0 | 3 | 0 |
| 2002 | 0 | 0 | 5 | 0 |
| 2003 | 0 | 0 | 2 | 0 |
| 2004 | 0 | 0 | 8 | 1 |
| 2005 | 1 | 0 | 11 | 0 |
| 2006 | 0 | 0 | 6 | 0 |
| 2007 | 2 | 0 | 13 | 2 |
| 2008 | 0 | 0 | 15 | 1 |
| 2009 | 0 | 1 | 16 | 3 |
| 2010 | 0 | 1 | 29 | 2 |
| 2011 | 0 | 0 | 31 | 4 |
| 2012 | 0 | 0 | 32 | 1 |
| 2013 | 1 | 0 | 42 | 3 |
| 2014 | 0 | 1 | 64 | 4 |
| 2015 | 1 | 0 | 67 | 5 |
| 2016 | 2 | 2 | 85 | 13 |
| 2017 | 2 | 2 | 79 | 11 |
| 2018 | 0 | 2 | 103 | 9 |
| 2019 | 1 | 0 | 119 | 12 |
| 2020 | 3 | 2 | 99 | 11 |
| 2021 | 1 | 2 | 151 | 18 |
| 2022 | 1 | 0 | 168 | 16 |
| 2023 | 0 | 2 | 198 | 16 |
| 2024 | 3 | 1 | 182 | 14 |
| 2025 | 2 | 1 | 198 | 19 |
| 2026 | 2 | 5 | 193 | 21 |
22 studies match. 7 name the Lexical Decision Task in a primary outcome. Median size 60 participants. Median time to the primary outcome: 6 weeks.
Loading 22 studies; the filters turn on when they arrive.
2026 is partly planned starts.
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 2 | 0 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 3 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 3 | 1 |
| 2025 | 2 | 1 |
| 2026 | 2 | 1 |
Lead sponsor: industry 1, other 21. Interventional 18, observational 4.
As a primary outcomeSecondary or other outcomeThe Lexical Decision Task
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07904325 | Start2026 | PhaseObservational | ConditionsCardiovascular disease, Lung disease | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07546292 | Start2026 | PhaseNot applicable | ConditionsOther conditions | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07383311 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants76 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06981351 | Start2025 | PhaseNot applicable | ConditionsOther conditions | Participants288 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06870552 | Start2024 | PhaseNot applicable | ConditionsOther conditions | Participants36 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06619756 | Start2024 | PhaseNot applicable | ConditionsOther conditions | Participants2 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06384495 | Start2024 | PhaseNot applicable | ConditionsStroke | Participants3 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT05672771 | Start2020 | PhaseNot applicable | ConditionsAging, frailty and exercise | Participants90 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05629520 | Start2020 | PhaseObservational | ConditionsDepression and bipolar disorder | Participants60 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05137353 | Start2021 | PhaseNot applicable | ConditionsOther conditions | Participants51 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04942574 | Start2022 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants30 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04244578 | Start2016 | PhaseNot applicable | ConditionsOther conditions | Participants28 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04159012 | Start2020 | PhaseNot applicable | ConditionsDepression and bipolar disorder | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT04041960 | Start2019 | PhaseNot applicable | ConditionsOther conditions | Participants28 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT03600987 | Start2017 | PhaseNot applicable | ConditionsStroke | Participants4 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT03233542 | Start2017 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants87 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT03017560 | Start2015 | PhaseNot applicable | ConditionsCancer | Participants45 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT02875938 | Start2016 | PhaseNot applicable | ConditionsStroke | Participants1 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT01858818 | Start2013 | PhaseObservational | ConditionsSubstance use and addiction | Participants75 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT00664300 | Start2007 | PhaseObservational | ConditionsOther conditions | Participants60 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT00664157 | Start2007 | PhaseNot applicable | ConditionsParkinson's disease | Participants80 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT00191906 | Start2005 | PhasePhase 4 | ConditionsADHD | Participants121 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
22 registered studies on ClinicalTrials.gov name it in an outcome measure, 7 of them in a primary outcome.
Most often in stroke (3), depression and bipolar disorder (2) and dementia and Alzheimer's disease (1).
The Serial Naming Task (3 studies), the Stroop Color-Word Test (3 studies) and Emoji Emotion Recognition (2 studies).
4 of the 15 completed studies that name it, 27%, have reported results: 2 posted them on ClinicalTrials.gov, 3 have a results paper linked to the registry record, and 1 did both. The other 11 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.